“From Pharmaco-economics
to Health Technology Assessment (HTA)”
Can Radiopharmaceuticals
be HTA compatible for Reimbursement?
Dr Konrade von Bremen
17 February 2010 at 10:30
Hilton Conrad Hotel Brussels
The challenge for any pharmaceutical industry is to obtain reimbursement from health insurance fees in a timely fashion.
Different hurdles have been put in place before obtaining the full market recognition with adequate reimbursement. After clinical evidence, pharmaco-economic analysis became compulsory for submission to authorities.
Health Technology Assessment is the current gold standard for a reimbursement dossier in most countries. Can Radiopharmaceuticals be HTA compatible...
...for reimbursement?
Different hurdles have been put in place before obtaining the full market recognition with adequate reimbursement. After clinical evidence, pharmaco-economic analysis became compulsory for submission to authorities.
Health Technology Assessment is the current gold standard for a reimbursement dossier in most countries. Can Radiopharmaceuticals be HTA compatible...
...for reimbursement?
Dr Konrade von Bremen is CEO of the SWAN-Group (Bern, Switzerland), a Holding that aims at fostering technological advances in medicine through the set-up of a radiopharmaceutical production unit and distribution network as well as through the design, concept, planning and operation of a privately financed proton therapy center in Switzerland.
now playing :
- Joanna Newsom - Have One OnMe
- Ilyas Ahmed - Goner
- Quasi - American Gong
- Jaga Jazzist - One Armed Bandit
- Motorpsycho - Heavy Metal Fruit
- A Silver Mt Zion - Kollaps Tradixionales
now playing :
- Joanna Newsom - Have One OnMe
- Ilyas Ahmed - Goner
- Quasi - American Gong
- Jaga Jazzist - One Armed Bandit
- Motorpsycho - Heavy Metal Fruit
- A Silver Mt Zion - Kollaps Tradixionales
